Residency · Residency · Anesthesiology

Traumatic Brain Injury: Intraoperative and ICU Management

Introduction

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. The anesthesiologist plays a pivotal role in managing the TBI patient during emergent surgical decompression and in the intensive care unit. The central goal is to prevent secondary brain injury by maintaining adequate cerebral perfusion, oxygenation, and metabolic homeostasis.

Classification of TBI

TBI is classified by severity using the Glasgow Coma Scale: mild (GCS 13 to 15), moderate (GCS 9 to 12), and severe (GCS 3 to 8, requiring intubation and ICU management). Primary injury occurs at the moment of impact and includes contusion, diffuse axonal injury, epidural and subdural hematoma, and intraparenchymal hemorrhage. Secondary injury, which is the focus of all therapeutic interventions, encompasses ischemia, hypoxia, hypotension, cerebral edema, excitotoxicity, and inflammation.

Cerebral Physiology Review

Cerebral blood flow is normally approximately 50 mL/100g/min and is regulated by autoregulation, PaCO2, PaO2, and metabolic demand. Cerebral perfusion pressure is calculated as MAP minus ICP, with a target of 60 to 70 mmHg in adults. Autoregulation maintains constant cerebral blood flow across a MAP range of 50 to 150 mmHg but is frequently impaired after TBI.

CO2 reactivity remains an important regulatory mechanism: cerebral blood flow changes approximately 3% per mmHg change in PaCO2 within the range of 20 to 80 mmHg. Hyperventilation reduces cerebral blood flow and ICP but risks cerebral ischemia.

The Monro-Kellie doctrine states that the cranium is a fixed volume containing brain (approximately 80%), blood (approximately 10%), and CSF (approximately 10%). An increase in one component must be compensated by a decrease in another, or ICP will rise.

Initial Resuscitation and Airway Management

All patients with a GCS of 8 or below should be intubated for airway protection. Hypotension must be avoided, as even a single episode of systolic blood pressure below 90 mmHg doubles mortality in severe TBI. Hypoxia must also be avoided, with a target SpO2 above 90% and PaO2 above 60 mmHg. Rapid sequence induction with cervical spine precautions is performed, since up to 10% of severe TBI patients have concurrent cervical spine injury.

For induction, propofol at 1 to 2 mg/kg reduces CMRO2 and ICP but must be used cautiously in hypotension. Etomidate at 0.2 to 0.3 mg/kg is hemodynamically stable and reduces ICP. Ketamine was previously avoided due to theoretical ICP concerns, but recent evidence supports its safety when ventilation is controlled, and it may be preferred in hypotensive patients. Rocuronium at 1.2 mg/kg provides rapid onset neuromuscular blockade. Lidocaine at 1.5 mg/kg IV blunts the sympathetic response to laryngoscopy and reduces the ICP spike. Nasal intubation should be avoided in suspected basilar skull fracture.

Intraoperative Management

Monitoring

An arterial line should be placed before induction if possible for continuous blood pressure and arterial blood gas monitoring. A central venous catheter is needed for vasoactive drug administration and CVP monitoring. Core temperature monitoring, urinary catheter for output monitoring and osmotherapy assessment, and ICP monitoring (ventriculostomy or intraparenchymal bolt) placed by neurosurgery are all essential. Processed EEG monitoring may guide anesthetic depth.

Hemodynamic Goals

The MAP target should be sufficient to maintain a CPP of 60 to 70 mmHg, often requiring a MAP of 80 to 100 mmHg depending on the ICP. Systolic blood pressure should not fall below 100 mmHg per Brain Trauma Foundation guidelines. Vasopressors such as norepinephrine and phenylephrine are used as needed. Vasodilators including nitroprusside, nitroglycerin, and hydralazine should be avoided because they increase cerebral blood flow and may raise ICP.

Ventilation Strategy

The default target is normocapnia with a PaCO2 of 35 to 40 mmHg. Hyperventilation to a PaCO2 of 30 to 35 mmHg is used only as a temporizing measure for acute herniation, identified by a blown pupil or posturing. Prolonged hyperventilation below a PaCO2 of 30 mmHg should be avoided due to the risk of cerebral ischemia. PaO2 should be maintained above 60 mmHg, and hyperoxia (PaO2 above 300 mmHg) should also be avoided because it may increase oxidative stress. Lung-protective tidal volumes of 6 to 8 mL/kg of ideal body weight with moderate PEEP of 5 to 8 cmH2O are used; PEEP up to 12 to 15 cmH2O is generally safe as long as MAP is maintained.

Anesthetic Technique

TIVA with propofol and remifentanil is preferred because it reduces CMRO2, lowers ICP, and allows rapid neurologic assessment. Volatile agents at less than 1 MAC are acceptable but may impair autoregulation and increase ICP at higher concentrations. Nitrous oxide should be avoided because it increases CMRO2 and expands pneumocephalus. Neuromuscular blockade should be maintained during ICP-critical periods to prevent coughing and straining. Fluid overload should be avoided, and isotonic crystalloid (0.9% NaCl or balanced solutions) is used for maintenance.

Positioning

The head should be elevated 30 degrees to promote venous drainage and reduce ICP. The head is kept in a neutral position, and neck flexion, rotation, or tight-fitting cervical collars that impede jugular venous outflow must be avoided. The ETT must be secured firmly because accidental extubation during a craniotomy is catastrophic.

ICP Management Strategies

Tier 1 (First-Line)

First-line measures include head of bed elevation to 30 degrees with the head in midline position, adequate sedation and analgesia (propofol, fentanyl or remifentanil), CSF drainage via ventriculostomy if available, normothermia with aggressive treatment of fever, normocapnia with a PaCO2 of 35 to 40 mmHg, and seizure prophylaxis with levetiracetam or phenytoin for 7 days.

Tier 2

Second-tier interventions include hyperosmolar therapy. Mannitol is given at 0.25 to 1 g/kg IV bolus, with serum osmolality monitored and kept below 320 mOsm/kg and vigilance for hypovolemia. Hypertonic saline (23.4% NaCl at 30 mL bolus or 3% NaCl infusion targeting a sodium of 145 to 155 mEq/L) is preferred in hypovolemic patients. Brief hyperventilation to a PaCO2 of 30 to 35 mmHg is used for acute herniation, and CPP is optimized with vasopressors.

Tier 3

Third-tier interventions include decompressive craniectomy, which removes a bone flap to allow brain expansion and reduces ICP, though long-term functional outcomes are debated (DECRA, RESCUEicp trials). Barbiturate coma with pentobarbital (loading dose 5 to 10 mg/kg, then 1 to 3 mg/kg/hr) requires continuous EEG to titrate to burst suppression and causes significant hemodynamic depression. Therapeutic hypothermia to 32 to 35 degrees Celsius has mixed evidence but may be considered for refractory ICP in select cases.

ICU Management Priorities

Continuous ICP and CPP monitoring with protocol-driven interventions is the foundation of ICU care. Euvolemia should be maintained, and hypotonic fluids avoided due to the risk of cerebral edema. Glucose management targets avoidance of hypoglycemia with a glucose target of 140 to 180 mg/dL. DVT prophylaxis begins with mechanical compression (SCDs) initially, with pharmacologic prophylaxis (enoxaparin) started when safe from the neurosurgical perspective, typically 24 to 72 hours post-injury. Enteral nutrition should be initiated within 24 to 48 hours.

Secondary complications that require monitoring and treatment include diabetes insipidus, cerebral salt wasting, SIADH, paroxysmal sympathetic hyperactivity, and coagulopathy.

Sodium and Water Disorders in TBI

Diabetes insipidus presents with large volumes of dilute urine (more than 300 mL/hr) and rising serum sodium. Treatment consists of desmopressin (DDAVP) 1 to 2 mcg IV and free water replacement. Cerebral salt wasting causes hyponatremia with volume depletion and natriuresis, and is treated with isotonic or hypertonic saline volume repletion. SIADH causes hyponatremia with euvolemia and is managed with fluid restriction and hypertonic saline if severe.

Clinical Pearls

Preventing secondary brain injury is the fundamental principle: hypotension (systolic blood pressure below 90 to 100 mmHg) and hypoxia (SpO2 below 90%) must be avoided at all costs. Hyperventilation is a temporizing measure for herniation, not a maintenance strategy, because prolonged hypocapnia worsens cerebral ischemia. Hypertonic saline has largely replaced mannitol as the preferred hyperosmolar agent because it expands intravascular volume rather than causing diuresis. TIVA with propofol and remifentanil is the preferred anesthetic technique for neurosurgery because it reduces ICP, lowers CMRO2, and allows rapid neurologic assessment. Acute changes in pupil size or new lateralizing signs demand immediate intervention: hyperventilate, administer hyperosmolar therapy, and communicate urgently with neurosurgery.

References

1. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, 4th edition. Neurosurgery. 2017;80(1):6-15.
2. Hutchinson PJ, Kolias AG, Timofeev IS, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension (RESCUEicp). N Engl J Med. 2016;375(12):1119-1130.
3. Oddo M, Crippa IA, Mehta S, et al. Optimizing sedation in patients with acute brain injury. Crit Care. 2016;20:128.
4. Stocchetti N, Maas AI. Traumatic intracranial hypertension. N Engl J Med. 2014;370(22):2121-2130.

Read this lecture as Markdown